1. Colorectal cancer screening. For the purposes of this section, "colorectal cancer screening" means all colorectal cancer examinations and laboratory tests recommended by a health care provider in accordance with the most recently published colorectal cancer screening guidelines of a national cancer society. [PL 2019, c. 86, §4 (AMD); PL 2019, c. 86, §10 (AFF).] 2. Required coverage. All group health insurance policies, contracts and certificates must provide coverage for colorectal cancer screening for asymptomatic individuals who are: A. At average risk for colorectal cancer according to the most recently published colorectal cancer screening guidelines of a national cancer society; or [PL 2019, c. 86, §5 (AMD); PL 2019, c. 86, §10 (AFF).] B. At high risk for colorectal cancer. [PL 2019, c. 86, §6 (AMD); PL 2019, c. 86, §10 (AFF).] [PL 2019, c. 86, §§5, 6 (AMD); PL 2019, c. 86, §10 (AFF).] 3. Billing. If a colonoscopy is recommended by a health care provider as the colorectal cancer screening test in accordance with this section and a lesion is discovered and removed during that colonoscopy, the health care provider must bill the insurance company for a screening colonoscopy as the primary procedure. [PL 2007, c. 516, §3 (NEW); PL 2007, c. 516, §5 (AFF).] REVISOR'S NOTE: §2847-N. Coverage for medically necessary infant formula (As enacted by PL 2007, c. 595, §3 is REALLOCATED TO TITLE 24-A, SECTION 2847-P)
‹ Prev All Maine sections Next ›
Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.